All 12 sets of NSD3 blotting data were combined and results showed that NSD3 protein upregulation in pancreatic cancer tissues was significant (P < 0.05 vs. normal pancreatic tissues, Fig. 1F). This evidence concerns the gene NSD3 and familial pancreatic carcinoma.